Back to search
FDAFDA · Food and drugs·Recall number D-1495-2016

Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)

Published September 14, 2016 · Recall initiated: June 17, 2016

Summary

FDA records drug Class II recall D-1495-2016, published September 14, 2016 and initiated June 17, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 92,480 containers; Lot: All Lots Within Expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva North America
Distributor
Nationwide and Puerto Rico
Lot
All Lots Within Expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers) recalled?

Yes. FDA published recall D-1495-2016 on September 14, 2016. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter